{"grounding": "Although diabetic retinopathy (DR) is clinically diagnosed as a vascular disease, many studies find retinal neuronal and visual dysfunction before the onset of vascular DR. This suggests that DR should be viewed as a neurovascular disease. Prior to the onset of DR, human patients have compromised electroretinograms that indicate a disruption of normal function, particularly in the inner retina. They also exhibit reduced contrast sensitivity. These early changes, especially those due to dysfunction in the inner retina, are also seen in rodent models of diabetes in the early stages of the disease. Rodent models of diabetes exhibit several neuronal mechanisms, such as reduced evoked GABA release, increased excitatory glutamate signaling, and reduced dopamine signaling, that suggest specific neuronal deficits. This suggests that understanding neuronal deficits may lead to early diabetes treatments to ameliorate neuronal dysfunction.", "generated_text": "Diabetes-induced visual dysfunction is a significant complication affecting the retina, a complex neural tissue critical for vision. This study investigates the physiological changes in retinal neurons of both human and rodent models, including mice and rats, with diabetes. Utilizing advanced imaging and electrophysiological techniques, we observed alterations in rod and cone photoreceptors, as well as in bipolar and ganglion cells, which are key components of the retinal circuitry. These changes include reduced photoreceptor sensitivity, disrupted synaptic transmission, and increased oxidative stress, leading to impaired visual processing. Our findings highlight the multifaceted nature of diabetic retinopathy and provide insights into potential therapeutic targets for mitigating visual dysfunction in diabetic patients.", "label": 1}